Hospitals face a multi-million dollar dilemma: upgrade aging imaging hardware or accept degraded scan quality.

SubtleHD(CT) joins Subtle’s other AI medical imaging products including SubtlePET and SubtleHD(MR) that aim to improve PET and MR images, respectively.

Health Canada has granted approval to Subtle Medical’s magnetic resonance imaging (MRI) enhancement software, SubtleHD.

Subtle Medical's new product, SubtleHD™(CT), receives FDA clearance, enhancing CT image quality using AI-powered technology for better healthcare outcomes.

Subtle Medical announced FDA clearance of SubtleHD™(PET), an AI-powered solution enhancing PET imaging by improving quality and speed.

Subtle Medical has introduced SubtleHD™ in the UK, enhancing MRI imaging speed and image quality through AI. This software boosts efficiency and patient care.

Subtle Medical anticipates a significant 2.5x revenue increase in 2025, driven by AI advancements in medical imaging and enterprise demand.

Subtle Medical's SubtleHD™ now available in Brazil after receiving ANVISA approval, aiming to improve MRI imaging and operational efficiency.

Subtle Medical has launched its AI-driven imaging software, SubtleHD™, in Chile through a partnership with Hospiline to enhance MRI efficiency.

Subtle Medical has earned CE Mark certification for SubtleHD™, revolutionizing MRI imaging with tremendous quality and speed across Europe.

Subtle Medical's SubtleHD™ gains FDA clearance, introducing groundbreaking enhancements in MRI imaging quality and speed, setting new industry standards.

New software enhances CT image quality across scanner generations, supporting radiologists with improved image clarity and consistency MENLO PARK, Calif., June 10, 2026 /PRNewswire/ -- Subtle Medical, a leader in AI-powered medical imaging software, today announced FDA clearance for...

The new solution supports all FDA-approved radiotracers and enables up to 75% faster PET imaging on existing scanners MENLO PARK, Calif., May 27, 2026 /PRNewswire/ -- Subtle Medical, a leader in AI-powered medical imaging software, today announced the FDA clearance of SubtleHD™(PET), its...

MENLO PARK, Calif., Aug. 13, 2025 /PRNewswire/ -- Subtle Medical, a global leader in AI-powered medical imaging software, today announced SubtleHD™ obtained ANVISA regulatory approval and is now commercially available in Brazil, marking a significant milestone in expanding access to...

SubtleHD sets a new benchmark in image quality and speed for European MRI providers. MENLO PARK, Calif., March 17, 2025 /PRNewswire/ -- Subtle Medical, a global leader in AI-powered medical imaging enhancement, announced today that SubtleHD™ has received…

With FDA clearance of SubtleHD™, Subtle Medical launches Subtle-ELITE™, an industry-first AI package designed to achieve superior image quality, unprecedented speed, and workflow automation MENLO PARK, Calif., Feb. 13, 2025 /PRNewswire/ -- Subtle Medical,…

MENLO PARK, Calif., May 29, 2025 /PRNewswire/ — Subtle Medical, a global leader in AI-powered medical imaging software, announced today the commercial availability of SubtleHD™ in Chile, marking an important step in expanding access to advanced imaging solutions across Latin America. The company also confirmed it will partner with Hospiline, a trusted regional distributor that currently …